|
Jul 23
|
Lantheus to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025, at 8:00 a.m. Eastern Time
|
|
Jul 22
|
Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D
|
|
Jul 18
|
Lantheus (LNTH): Buy, Sell, or Hold Post Q1 Earnings?
|
|
Jul 16
|
Why Lantheus (LNTH) Stock Is Down Today
|
|
Jul 11
|
Lantheus, ICU Medical, Haemonetics, CONMED, and Astrana Health Shares Plummet, What You Need To Know
|
|
Jul 2
|
Lantheus’s Q1 Earnings Call: Our Top 5 Analyst Questions
|
|
Jun 30
|
Riley Maintains ‘Buy’ Rating on Lantheus Holdings, Inc. (LNTH); Lowers PT
|
|
Jun 28
|
Lantheus Joins FIBRE Consortium with Pfizer, Lumina to Revolutionize Fibrotic Disease Treatment
|
|
Jun 24
|
Lantheus to Present New Oncology Radiodiagnostic Data at SNMMI Meeting
|
|
Jun 24
|
Spotting Winners: Lantheus (NASDAQ:LNTH) And Medical Devices & Supplies - Imaging, Diagnostics Stocks In Q1
|
|
Jun 20
|
Lantheus Holdings (NasdaqGM:LNTH) Joins FIBRE Consortium To Transform Fibrotic Disease Treatment
|
|
Jun 11
|
Lantheus Announces Presentations to be featured at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting
|
|
Jun 10
|
Lantheus to Present at the 2025 Truist Securities MedTech Conference
|
|
Jun 10
|
Declining Stock and Solid Fundamentals: Is The Market Wrong About Lantheus Holdings, Inc. (NASDAQ:LNTH)?
|
|
Jun 9
|
1 Value Stock Worth Investigating and 2 to Think Twice About
|
|
May 9
|
LNTH Q1 Earnings Call: Lantheus Lowers Outlook Amid Product Shifts and Divestitures
|
|
May 9
|
Lantheus price target lowered to $120 from $134 at JonesResearch
|
|
May 9
|
Lantheus Holdings, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
|
|
May 8
|
LNTH: Sale of SPECT Tilts Growth to Novel Radiopharmaceuticals
|
|
May 8
|
Lantheus Holdings First Quarter 2025 Earnings: Misses Expectations
|